Bertozzi Carolyn R 4

4 · ALNYLAM PHARMACEUTICALS, INC. · Filed Jan 9, 2023

Insider Transaction Report

Form 4
Period: 2023-01-05
Transactions
  • Award

    Stock Option (right to buy)

    2023-01-05+4,2684,268 total
    Exercise: $225.68Exp: 2033-01-05Common Stock (4,268 underlying)
Footnotes (1)
  • [F1]The stock option will vest as to one third of the shares on each of the first, second and third anniversaries of the date of grant.

Documents

1 file
  • 4
    edgardoc.xmlPrimary

    PRIMARY DOCUMENT